We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Erythrocyte Storage Duration Affects Membrane Deformability

By LabMedica International staff writers
Posted on 21 Mar 2013
Blood banks consider six weeks to be the standard shelf life of blood for use in transfusion, but this timescale may need to be shortened. More...


Erythrocyte cell membranes undergo morphologic changes during storage, but it is unclear whether these changes are reversible, as after three weeks red cells in stored blood lose their ability to deliver oxygen where it is most needed.

Doctors involved in critical care medicine at Johns Hopkins University School of Medicine (Baltimore MD, USA) examined the blood given to 16 patients undergoing spinal fusion surgery. They assessed erythrocyte cell membrane deformability in patients before and after transfusion to determine the effects of storage duration and whether changes in deformability are reversible after transfusion.

Deformability was measured in samples drawn directly from the blood storage bags before transfusion and in samples drawn from patients before and after three postoperative days post-transfusion. In samples taken from the blood storage bags, they compared deformability of erythrocytes stored for a long duration, equal to or more than 21 days, those stored for a shorter duration, less than 21 days, and cell-salvaged erythrocytes. Deformability was assessed quantitatively using the elongation index (EI) measured by microfluidic slit-flow ektacytometer (Rheo Meditech; Seoul, South Korea), a method that determines the ability for the cell to elongate when exposed to shear stress.

The scientist found that found that after three weeks, red blood cells were not flexible enough to squeeze down through the fine capillaries, as they were more likely to have stiffer cell membranes. They also found that even after transfusion into patients, erythrocytes in blood that has stood on the shelf for more than three weeks fail to regain the flexibility they once had. This was the case even when the blood was in the patient, where the donated red cells would be in the best environment to repair their injury: the correct acidity, oxygen, and electrolyte levels.

The team found that patients who received fewer units of blood had healthier red cells overall, regardless of how old the blood was that they received. This probably means that if the patient does not receive too many damaged cells their loss of flexibility is less of a problem than if the patient receives many of them. Steven M. Frank, MD, the lead author of the study, said, "There's more and more information telling us that the shelf life of blood may not be six weeks, which is what the blood banks consider standard. If I were having surgery tomorrow, I'd want the freshest blood they could find. Once red cells lose their flexibility; red cells probably stay that way for the rest of their lives, which is about 120 days in total." The study was published on February 28, 2013, in the journal Anesthesia & Analgesia.

Related Links:
Johns Hopkins University School of Medicine
Rheo Meditech


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.